Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04149145. IPD Sharing: NO. Countries: 0. Publications: 1.
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous o
ClinicalTrials.gov study NCT00520013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov study NCT00113373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Che
ClinicalTrials.gov study NCT00780039. IPD Sharing: YES. Countries: 0. Publications: 2.
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive
ClinicalTrials.gov study NCT01609556. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
ClinicalTrials.gov study NCT01074398. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
ClinicalTrials.gov study NCT05001347. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00023712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05963334. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
ClinicalTrials.gov study NCT03054909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05261490. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02440425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
ClinicalTrials.gov study NCT04034927. IPD Sharing: YES. Countries: 1. Publications: 0.
Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment
ClinicalTrials.gov study NCT01521143. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers
ClinicalTrials.gov study NCT01659554. IPD Sharing: NO. Countries: 1. Publications: 0.
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
ClinicalTrials.gov study NCT00090844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
ClinicalTrials.gov study NCT03606486. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT05751629. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05043402. IPD Sharing: NO. Countries: 0. Publications: 1.
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05715216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.